1. Colak,D., Zaninovic,N., Cohen,M.S., Rosenwaks,Z., Yang,W.Y., Gerhardt,J. (2014)
Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science, 343 (6174), 1002-1005.
2. Adams-Cioaba,M.A., Guo,Y., Bian,C., Amaya,M.F., Lam,R. (2010) Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2. PLoS ONE, 5, e13559.
3. Alpatov,R., Lesch,B.J., Nakamoto-Kinoshita,M., Blanco,A., Chen,S., Stützer,A.,
Armache,K.J., Simon,M.D., Xu,C., Ali,M., Murn,J., Prisic,S., Kutateladze,T.G., Vakoc,C.R., Min,J., Kingston,R.E., Fischle,W., Warren,S.T., Page,D.C., Shi,Y. (2014) A chromatin-dependentrole of the fragile X mental retardation protein FMRP in the DNA damage response. Cell, 157(4), 869-881.
4. Dolzhanskaya,N., Sung,Y.J., Conti,J., Currie,J.R., Denman,R.B. (2003) The fragile X mental retardation protein interacts with U-rich RNAs in a yeast three-hybrid system. Biochem Biophys Res Commun. 305, 434–441.
5. Halevy,T., Czech,C., Benvenisty,N. (2015) Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells. Stem Cell Rep, 4(1), 37-46.
6. Wang,H., Wu,L.J., Kim,S.S. (2008) FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron, 59(4), 634-647.
7. Sittler,A., Devys,D., Weber,C., Mandel,J.L. (1996) Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of FMR1 protein isoforms. Hum Mol Genet, 5(1), 95-102.
8. Raymond,C.K., Castle,J., Garrett-Engele,P., Armour,C.D., Kan,Z. (2004)
Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem, 279, 46234–46241.
9. Loffreda,A., Rigamonti,A., Barabino,S.M., Lenzken,S.C. (2015) RNA-Binding Proteins in the Regulation of miRNA Activity: A Focus on Neuronal Functions. Biomolecules, 5(4), 2363-2387.
10. Chetkovich,D.M., Bunn,R.C., Kuo,S.H., Kawasaki,Y., Kohwi,M. (2002) Postsynaptic targeting of alternative postsynaptic density-95 isoforms by distinct mechanisms. J Neurosci, 22, 6415–6425.
11. Raingo,J., Castiglioni,A.J., Lipscombe,D. (2007) Alternative splicing controls G
protein-dependent inhibition of N-type calcium channels in nociceptors. Nat
12. Guo,X., Fu, X., Yan, A., Liao, J., Zhang, D., Ke,L., Lan, F. (2013) Identification of a novel cryptic exon in intron 9 region o f FMR1 gene among fragile X syndrome (Article in Chinese). Int J Lab Med, 34(1), 6-8.
13. Tseng, E., Tang, H-T., AIOIaby, RR., Hickey, L., Tassone, F. (2017) Altered expression of the FMR1 splicing variants landscape in permutation carriers. BBA-Gene Regulatory Mechanisms, 1860, 1117-1126.
14. Pan,Q., Shai,O., Lee,L.J., Frey,B.J., Blencowe,B.J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet, 40, 1413–1415.
15. Verkerk,A.J., de,Graaff.E., De,Boulle,K., Eichler,E.E., Konecki,D.S., Reyniers,E.,
Manca,A., Poustka,A., Willems,P.J., Nelson,D.L. (1993) Alternative splicing in the fragile X gene FMR1. Hum Mol Genet. 2, 399-404.
16. Xie,W., Dolzhanskaya,N., LaFauci,G., Dobkin,C., Denman,R.B. (2009) Tissue and developmental regulation of fragile X mental retardation 1 exon 12 and 15 isoforms. Neurobiol Disease, 35(1), 52-62
17. Pretto,D.I., Eid,J.S., Yrigollen,C.M., Tang,H.T., Loomis,E.W., Raske,C., Durbin-Johnson
B, Hagerman,P.J., Tassone,F. (2015) Differential increases of specific FMR1 mRNA isoforms in premutation carriers. J Med Genet. 52(1), 42-52.
18. Collins,S.C., Bray,S.M., Suhl,J.A., Cutler,D.J., Coffee,B., Zwick,M.E., Warren, S.T. (2010) Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am J Med Genet A, 152A(10), 2512-2520.
19. Pilaz,L.J., Lennox,A.L., Rouanet,J.P., Silver,D.L. (2016) Dynamic mRNA Transport and LocalTranslation in Radial Glial Progenitors of the Developing Brain. Curr Biol, 26(24), 3383-3392.
20. Tamanini,F., Kirkpatrick,L.L., Schonkeren,J., van,Unen.L., Bontekoe,C., Bakker, C., Nelson,D.L., Galjaard,H., Oostra,B.A., Hoogeveen,A.T. (2000) The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins. Hum Mol Genet, 9, 1487 – 1493.
21. Schenck,A., Bardoni,B., Moro,A., Bagni,C., Mandel,J.L. (2001) A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci U S A, 98, 8844–8849.
22. Banerjee,P., Schoenfeld,B.P., Bell,A.J., Choi,C.H., Bradley,M.P. (2010) Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein. J Neurosci, 30, 6782–6792.
23. Bonaccorso,C.M., Spatuzza,M., Di,Marco.B., Gloria,A., Barrancotto,G., Cupo,A.,
Musumeci,S.A., D'Antoni,S., Bardoni,B., Catania,M.V. (2015) Fragile X mental retardationprotein (FMRP) interacting proteins exhibit different expression patterns during development. Int J Dev Neurosci, 42, 15-23.
24. Kim, M., Bellini, M., Ceman, S. (2009) Fragile X mental retardation protein FMRP binds mRNAs in the nucleus. Mol Cell Biol, 29(1), 214-28.
25. Ceman,S., Brown,V., Warren,S.T. (1999) Isolation of an FMRP-associated
messenger ribonucleoprotein particle and identification of nucleolin and the
fragile X-related proteins as components of the complex. Mol Cell Biol, 19, 7925–7932.
26. El,Fatimy.R., Davidovic,L., Tremblay,S., Jaglin,X., Dury,A., Robert,C,De. Koninck.P., Khandjian,E.W. (2016) Tracking the Fragile X Mental Retardation Protein in a Highly Ordered Neuronal RiboNucleoParticles Population: A Link between Stalled Polyribosomes and RNA Granules. PLoS Genet, 12(7), e1006192.
27. He,Q,. Ge,W. (2014) FMRP: a new chapter with chromatin. Protein Cell, 5(12), 885-888.
28. Bear,M.F., Huber,K.M., Warren,S.T. (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370–377.
29. Narayanan,U., Nalavadi,V., Nakamoto,M., Thomas,G., Ceman,S. (2008) S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis–dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem. 283, 18478–18482.
30. Kim,S.H., Markham,J.A., Weiler,I.J., Greenough,W.T. (2008) Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc Natl Acad Sci USA. 105, 4429–4434.
31. Darnell,J.C., Klann,E., (2013) The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci, 16, 1530–1536.
32. Provenzano,G., Sgadò,P., Genovesi,S., Zunino,G., Casarosa,S., Bozzi,Y. (2015) Hippocampal dysregulation of FMRP/mGluR5 signaling in engrailed-2 knockout mice: a model ofautism spectrum disorders. Neuroreport, 26(18), 1101-1105.
33. Fatemi,S.H., Folsom,T.D., Kneeland,R.E., Liesch,S.B. (2011) Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anat Rec, 294, 1635–1645.
34. Hong,A., Zhang,A., Ke,Y., El,Idrissi.A., Shen,C.H. (2012) Downregulation of GABA(A) β subunits istranscriptionally controlled by FMR1p. J Mol Neurosci, 46(2), 272–275.
35. Vilar,M., Murillo-Carretero,M., Mira,H., Magnusson,K., Besset,V., Ibáñez,C.F. (2006) Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle. EMBO J, 25(6), 1219-1230.
36. Huang,E.J., Reichardt,L.F. (2003) TRK receptors: roles in neuronal signal transduction. Annu Rev Biochem, 27, 27.
37. Leal,G., Bramham,C.R., Duarte,C.B. (2017) BDNF and Hippocampal Synaptic Plasticity. Vitam Horm, 104, 153-195.
38. Busch,R., Baldus,M., Vogt,M.A., Berger,S.M., Bartsch,D., Gass,P., von,Bohlen., Und,Halbach.O. (2017) Effects of p75NTR deficiency on cholinergic innervation of the amygdala and anxiety-like behavior. J Neurochem.